Sanofi India Ltd — Board/Management Information 2019

Jul 29, 2019

291 h July 2019

The Secretary SSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, MUMBAI- 400 001

The Secretary The National Stock Exchange of India Limited Exchange Plaza, 51 h Floor Plot No. C/1, G Block Bandra-Kurla Complex, Sandra East, Mumbai 400 050

Appointment of Additional Director and Whole Time Director

Dear Sirs,

The Board of Directors of the Company at its Meeting held today approved the appointment of Mr. Cherian Mathew (DIN - 08522813) as Additional Director to hold the office up to the next Annual General Meeting of the Company.

The Board also approved appointment of Mr. Cherian Mathew as Whole Time Director for a period of 5 years with effect from 29th July 2019 subject to approval of the members of the Company. The Board appointed Mr. Cherian Mathew as Key Managerial Personnel of the Company.

Mr. Cherian Mathew is not related to any Director of the Company. He is not debarred from holding the office of Director by virtue of any SEBI order or any other Authority.

A brief profile of Mr. Cherian Mathew is enclosed.

Thanking you, I TED GIRISH TEKCHANDANI COMPANY SECRETARY

Profile of Mr. Cherian Mathew

Mr. Cherian Mathew joined Sanofi in 1993 (with the erstwhile Hoechst India Limited) as a Project Engineer. Over the last 26 years, he has held ever increasing responsibilities in India as well as with various other Sanofi affiliates over the world. He was the Site Director and General Manager for Aventis Pharma SA, Senegal, following on as Strategic Projects Director for Industrial Affairs Asia Pacific region based out of Singapore. He has been instrumental in leading sites and managing their performance. He returned back to India for a brief period between January 2011 and July 2013 where he was the Site Director of Sanofi India's site in Goa. Under his tenure in Goa, the site was expanded with a state of the art manufacturing facility which was later approved by the MHRA (British Health agency on behalf of the EU) and ANVISA (Brazilian Health authorities). He later moved on to the Asia Pacific Japan Industrial affairs region as its head based in Shanghai, China. He has been instrumental in developing and implementing the industrial strategy for Sanofi in the region.

Mr. Cherian Mathew started his career in 1987 with Shaw Wallace and then had a brief stint with Ranbaxy Laboratories Limited.

He graduated in Engineering from liT Kharaghpur in 1987.